Abveris
is a Massachusetts-based drug discovery platform that offers solutions such as antibody discovery and screeing for the healthcare industry... Read moreAbveris
is a Massachusetts-based drug discovery platform that offers solutions such as antibody discovery and screeing for the healthcare industry... Read more
News
Sep 16, 2022
BioSpace
Abveris: Enzolytics Inc. Announces Collaboration with Abveris to Discover Monoclonal Antibodies
Mar 10, 2022
Business Wire
Press Release: Abveris : Abveris Named as One of the Best Places to Work
Nov 23, 2021
Pharamceutical Technology
Abveris: Twist Bioscience agrees to acquire Abveris for $190m
Nov 22, 2021
Genomeweb
Abveris: Twist Bioscience Reports 17 Percent Growth of Fiscal Q4 Revenues, to Acquire Abveris
Nov 11, 2021
BioSpace
Abveris: Abveris Announces Multi-Target, Multi-Year Therapeutic Antibody Discovery Collaboration with Prometheus Biosciences
Sep 15, 2021
The Business Journals
Abveris: Abveris to relocate HQ from Canton to Quincy
Aug 24, 2021
BioSpace
Abveris: Abveris and Abilita Bio Announce a Discovery Collaboration to Develop Therapeutics for Challenging Membrane Protein Targets
Aug 16, 2021
EIN Presswire
Press Release: Abveris : Tracey Mullen, CEO of Abveris honored by World Biz Magazine Awards with "Top 100 Innovation CEO" Award
Jul 22, 2021
Citybizlist
Abveris: Abveris Announces Partnership with Foundery Innovations
Apr 22, 2021
PR Newswire
Press Release: Abveris : Abveris Deploys Second Berkeley Lights Beacon System to Expand Single B Cell Antibody Discovery Capacity
Abveris Competitors
1
2
3
4
5
6
7
8
9
10